These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8305830)
1. Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A. Zierz S; Neumann-Schmidt S; Jerusalem F Clin Investig; 1993 Oct; 71(10):763-9. PubMed ID: 8305830 [TBL] [Abstract][Full Text] [Related]
2. Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Zierz S; Engel AG Eur J Biochem; 1985 May; 149(1):207-14. PubMed ID: 3996401 [TBL] [Abstract][Full Text] [Related]
3. Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle. Zierz S; Engel AG Biochem J; 1987 Jul; 245(1):205-9. PubMed ID: 3663146 [TBL] [Abstract][Full Text] [Related]
4. Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency. Zierz S Clin Investig; 1994 Dec; 72(12):957-60. PubMed ID: 7711426 [TBL] [Abstract][Full Text] [Related]
5. Carnitine acyltransferases in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency. Neumann-Schmidt S; Zierz S Neuromuscul Disord; 1991; 1(4):253-60. PubMed ID: 1822803 [TBL] [Abstract][Full Text] [Related]
7. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features. Lehmann D; Motlagh L; Robaa D; Zierz S Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946 [TBL] [Abstract][Full Text] [Related]
8. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach. Joshi PR; Zierz S Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037 [TBL] [Abstract][Full Text] [Related]
9. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase. Brady PS; Brady LJ Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962 [TBL] [Abstract][Full Text] [Related]
10. Malonyl CoA inhibition of carnitine palmityltransferase in rat heart mitochondria. Paulson DJ; Ward KM; Shug AL FEBS Lett; 1984 Oct; 176(2):381-4. PubMed ID: 6489524 [TBL] [Abstract][Full Text] [Related]
11. Kinetic properties of carnitine palmitoyltransferase I in cultured neonatal rat cardiac myocytes. McMillin JB; Wang D; Witters LA; Buja LM Arch Biochem Biophys; 1994 Aug; 312(2):375-84. PubMed ID: 7913595 [TBL] [Abstract][Full Text] [Related]
12. Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. Mills SE; Foster DW; McGarry JD Biochem J; 1983 Jul; 214(1):83-91. PubMed ID: 6615474 [TBL] [Abstract][Full Text] [Related]
13. Acyl-CoA chain length affects the specificity of various carnitine palmitoyltransferases with respect to carnitine analogues. Possible application in the discrimination of different carnitine palmitoyltransferase activities. Murthy MS; Ramsay RR; Pande SV Biochem J; 1990 Apr; 267(1):273-6. PubMed ID: 2327985 [TBL] [Abstract][Full Text] [Related]
14. Time-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA. Zammit VA Biochem J; 1984 Mar; 218(2):379-86. PubMed ID: 6712621 [TBL] [Abstract][Full Text] [Related]
15. Effect of pH and acyl-CoA chain length on the conversion of heart mitochondrial CPT-I/CPTo to a high affinity, malonyl-CoA-inhibited state. Bieber LL; Wagner M Biochim Biophys Acta; 1996 Aug; 1290(3):261-6. PubMed ID: 8765129 [TBL] [Abstract][Full Text] [Related]
16. Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation. Kashfi K; Mynatt RL; Cook GA Biochim Biophys Acta; 1994 May; 1212(2):245-52. PubMed ID: 8180250 [TBL] [Abstract][Full Text] [Related]
17. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. McGarry JD; Mills SE; Long CS; Foster DW Biochem J; 1983 Jul; 214(1):21-8. PubMed ID: 6615466 [TBL] [Abstract][Full Text] [Related]
18. Different sensitivities of CPT I and CPT II for inhibition by l-aminocarnitine in human skeletal muscle. Traufeller K; Gellerich FN; Zierz S Biochim Biophys Acta; 2004 Feb; 1608(2-3):149-54. PubMed ID: 14871492 [TBL] [Abstract][Full Text] [Related]